Europe Inferior Vena Cava Filter Market

Europe Inferior Vena Cava Filter Market Size

The size of the Europe inferior vena cava filter market was valued at USD 249.8 million in 2024. This market is expected to grow at a CAGR of 8.92% from 2025 to 2033 and be worth USD 539 million by 2033 from USD 272 million in 2025.

MARKET DRIVERS

Rising Geriatric Population and Chronic Illnesses Fuel IVC Filters Demand

The growing aging population in European countries is significantly boosting the demand for IVC filters in this region. Nearly 15% of the population in this region is aged 65 years and above. More than 34% of the population is expected to be aged 60 years and above by 2050, and this region is considered to retain the most aged population in the upcoming years.

Additionally, growing expenditure on healthcare and rising incidences of chronic diseases are leveling up the growth rate of the European IVC Filters Market. About 17.3 million people lost their lives due to cardiovascular diseases, and it is predicted that it will reach 23.3 million by 2030, according to the World Health Organization (WHO).

MARKET RESTRAINTS

High Procedure Costs and Low Awareness Limit IVC Filters Market Growth

The IVC filters placement procedures' cost is so expensive is a key factor restraining the market growth during the analysis period. Less knowledge about the inferior vena cava filters regarding the medical conditions and the different treatment options, and they highly depend on medical advice from professionals hampering the market growth during the estimated period.

REPORT COVERAGE

COUNTRY LEVEL ANALYSIS

The inferior vena cava filter market in Europe is anticipated to showcase promising growth and has occupied the second-largest market share following North America. The rising number of cardiovascular diseases is an essential factor responsible for market growth in this region. The Eastern European market shows promising growth and will contribute further to the European market, which currently occupies the second-largest share in the global market.

The United Kingdom is expected to dominate the largest share of the European IVC filter market. Advanced technologies can boost the production rate of new materials utilized for reducing the production cost, and providing greater endurance is fueling the growth. Advanced technologies and research and development activities in medical imaging have made the IVC filter process easy and effective. Moreover, advances in medical imaging help to minimize the risk and the exactness of the procedure. An increasing number of hospitals govern the market, and the surgeries needed for cardiovascular diseases are mounting considerably. Having awareness among people and increasing the number of patients diagnosed with CVD, and surging government initiatives and measurements to raise awareness of the devices utilized for the treatment are influencing the market growth.

KEY MARKET PLAYERS

Some of the key players in the European inferior vena cava filter market include C.R. Bard, Boston Scientific, Cardinal Health, Cook Medical, B.Braun, ALN, Braile Biomedica, Philips Volcano, Argon Medical Devices, and VENITI.

MARKET SEGMENTATION

This Europe inferior vena cava filter market research report is segmented and sub-segmented into the following categories.

By Application

• Treatment of Venous Thromboembolism

• Preventive Pulmonary Embolism

By Product Type

• Retrievable IVC

• Permanent IVC

By Material

• Non-Ferromagnetic Material

• Ferromagnetic Material

By End User

• Hospitals

• Ambulatory Surgical Centers

• Others

By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe